NYSE: CTVACorteva Inc Stock
$57.13-0.42 (-0.73%)
Updated May 15, 2024
CTVA Price
$57.13
Fair Value Price
N/A
Market Cap
$39.82B
52 Week Low
$43.22
52 Week High
$58.81
P/E
72.32x
P/B
1.61x
P/S
2.4x
PEG
0.65x
Dividend Yield
1.1%
Revenue
$16.83B
Earnings
$559.00M
Gross Margin
42.4%
Operating Margin
5.29%
Profit Margin
3.3%
Debt to Equity
0.75
Operating Cash Flow
$2B
Beta
0.91
Next Earnings
N/A
Ex-Dividend
Jun 4, 2024
Next Dividend
Jun 18, 2024
CTVA Overview
Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and disease, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, below-ground nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. is headquartered in Wilmington, Delaware.
Zen Score
–
Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CTVA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CTVA ($57.13) is trading above its intrinsic value of $35.10, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CTVA is poor value based on its earnings relative to its share price (72.32x), compared to the US market average (31.36x)
P/E vs Market Valuation
CTVA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CTVA due diligence checks available for Premium users.
Be the first to know about important CTVA news, forecast changes, insider trades & much more!
CTVA News
Valuation
CTVA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
72.32x
Industry
37.74x
Market
31.36x
CTVA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CTVA is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CTVA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.61x
Industry
1.42x
CTVA is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CTVA price to earnings growth (PEG)
For valuing profitable companies with growth potential
CTVA is good value based... subscribe to Premium to read more.
PEG Value Valuation
CTVA's financial health
Profit margin
Revenue
$4.5B
Net Income
$419.0M
Profit Margin
9.3%
CTVA's Earnings (EBIT) of $891.00M... subscribe to Premium to read more.
Interest Coverage Financials
CTVA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$43.6B
Liabilities
$18.6B
Debt to equity
0.75
CTVA's short-term assets ($17.16B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CTVA's short-term assets ($17.16B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CTVA's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CTVA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.6B
Investing
-$270.0M
Financing
$1.8B
CTVA's operating cash flow ($2.47B)... subscribe to Premium to read more.
Debt Coverage Financials
CTVA vs Agricultural Input Stocks
Corteva Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.